Has the price pet share for the offering been published

Dud as usual you are not in touch with reality. What is going to happen over the next year is this. Partnerships are formed. Trials are completed successfully. Stock climbs to 2-3 dollars. They will have a secondary and a 5 for 1 reverse split at that point so the big boys can get in the game. The sky is the limit from there.

Take a look at Ipix for the next generation of antibiotics.

I believe GS did not invite Amrn to make a presentation and then ignore a potential blockbuster. They are preparing their information and letting their internal and external preferred clients have a preview.

E, your arguments are sound. Big pharma and the financial community do not believe it is profitable enough to invest in antibiotics. NIH may have to take the lead in this field

PJ I would purchase a magic 8 ball before relying on dud for stock advise.

A partnership deal or two would be great for the company and shareholders. Only those working for shorts would think otherwise.

James giving the president a 3mm business gift violates U.S. constitution. Smile and say NO in your best Irish accent

Scott. You really have little idea what you are spouting. The NJ / Philadelphia corridor has more pharmaceutical representation than any area in the country. Don't know where you're from but you need to review your economic geography

Can anyone estimate how much cash the company has at this point?

When and where is meeting

News. Out

Najarian gloating on Cnbc about Amrn move. Noted that naysayers are clearly wrong about this stock

Dud the answer is easy. He spent all the money on shareholder interests

Jon spoke. Call options that expire next Friday were discussed. Over 6k purchased today. He stated he bought Amrn options today after seeing the activity.

The call options were up severely and expire in a week. He stated he purchased some today. He has always liked the stock and clearly expects news in next 7 days

Najarian points out hi options volume in Amrn.

Congratulations to those who engineered the one day manipulation of this stock. It was well planned and executed. Hopefully no one was hurt too badly.

Any word on ITC settlement? Seems long overdue

Based on several inputs many trial participants have clearly survived beyond expectations. Because of the crossover design,the final unbounded results may be difficult to interpret. Thus The fda may consider this a single arm trial. Question, has the fda ever approved a drug based on a single arm study with strong results?

If a company is not profitable/ or cash poor(like a start up),the usual method of reward is a stock option. It gives the employee leveraged upside, serves as golden handcuffs and costs the company no cash

Senti super summary. Based on the various complications and odd cross over design, could the results be so muddy that no statistical conclusions cam be drawn?

The question is will NWBO present results at ASCO? That would be worrisome for any company currently investigating alternative strategies.

As usual the shorts were wrong. Next announcement partnership fully funding p3. It will be a quick phase. Top line results by year end.

As anyone over 65 knows Medicare is not free. In addition you need a supplement to for expenses Medicare does not cover
There are a multitude of ways to make this work and keep private companies in business and provide coverage for all. Even harry Truman proposed such a plan. 70 years later it's time. We gave wall st. Trillions. We can give the public the same

If you own Ipix shares, you currently own a .12 option that doesn't expire. Don't let the shorts have your shares. They would like nothing better than to bankrupt the company and never have to cover their questionable trading practices

Can someone explain the nearly $150 million (in additional stock?) the company wants to authorize the board to control at their discretion?

Is there a conference call scheduled after European meeting?

AVII. Can you give your opinion on the adjudication process line of thought and it's affect on the statistical results

Any deal will be announced after European meeting. Not before. Any negative posts before then are just noise by shorts

BB. Any ITC activity

Tool mom to the cardiologist today. Spoke to him 6 months ago about v. Little reaction from him. This time he couldn't stop talking about the results, bhatts standing ovation, reduction in mace events. Etc. He is looking into it as an investment because he prescribes so much

Thx whal & bfrost for the insurance analysis

Does soc and Ada guidelines influence insurance companies? Particularly if the fad only approves a limited label expansion.

Couple of questions. Does anyone have contact with any actual study participants? Feedback? Will results be out by June? Can Nwbo still present at Pasco?

Its almost the end of q1. News?

If the trial was stopped in'15 or any other time, wouldn't that be a material event that would have to be disclosed.

Very important vacepa presentation Monday pm

Dew notes on another board that 3 big pharma have added more than $12 billion to their war chests on top of their already big cash holdings

New partner likely euro big pharma. Filing suggests they want 100% of European market and they want it working on the same approval track as fda. Glta longs